Morrisville.

PositionTriangle - ParagonDx get approval from fda - Brief article

MORRISVILLE -- ParagonDx won permission from the federal Food and Drug Administration to sell its first product--a genetic test that can identify heart-attack and stroke patients likely to bleed excessively if they take Coumadin, a common blood thinner. The company...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT